“Formulation and Evaluation of in-Situ Gel for Otic Administration of Rivastigmine for the Treatment of Alzheimerś Disease”. 2025. Vascular and Endovascular Review 8 (15s): 24-33. https://verjournal.com/index.php/ver/article/view/1113.